替考拉宁治疗期间出现的凝固酶阴性葡萄球菌及其敏感性测定。 - Suppr | 超能文献

Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.

作者信息

Jones R N

出版信息

J Antimicrob Chemother. 1992 Jun;29(6):725-7. doi: 10.1093/jac/29.6.725.

DOI:10.1093/jac/29.6.725

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Coagulase-negative staphylococci emerging during teicoplanin therapy and the determination of their sensitivity.替考拉宁治疗期间出现的凝固酶阴性葡萄球菌及其敏感性测定。

J Antimicrob Chemother. 1992 Jun;29(6):725-7. doi: 10.1093/jac/29.6.725.

2

Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity.

J Antimicrob Chemother. 1991 Apr;27(4):475-80. doi: 10.1093/jac/27.4.475.

3

Teicoplanin in the treatment of infections caused by coagulase-negative staphylococci.替考拉宁治疗凝固酶阴性葡萄球菌引起的感染。

J Antimicrob Chemother. 1988 Jan;21 Suppl A:93-103. doi: 10.1093/jac/21.suppl_a.93.

4

Teicoplanin-resistant coagulase-negative staphylococcus.

Lancet. 1986 Oct 25;2(8513):973. doi: 10.1016/s0140-6736(86)90622-7.

5

[Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].[糖肽类药物对儿科病房分离的凝固酶阴性葡萄球菌的体外活性比较]

Pathol Biol (Paris). 1992 Jan;40(1):36-9.

6

Teicoplanin-resistant coagulase-negative staphylococci.

Lancet. 1987 Jan 3;1(8523):39. doi: 10.1016/s0140-6736(87)90724-0.

7

Teicoplanin-resistant coagulase-negative staphylococci.耐替考拉宁凝固酶阴性葡萄球菌

Lancet. 1987 Feb 7;1(8528):328. doi: 10.1016/s0140-6736(87)92056-3.

8

Characterisation of coagulase-negative staphylococci isolated from blood infections: incidence, susceptibility to glycopeptides, and molecular epidemiology.从血液感染中分离出的凝固酶阴性葡萄球菌的特征：发病率、对糖肽类的敏感性及分子流行病学

Eur J Clin Microbiol Infect Dis. 2002 Sep;21(9):660-5. doi: 10.1007/s10096-002-0799-9. Epub 2002 Sep 7.

9

Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.

Biomed Pharmacother. 1991;45(1):43. doi: 10.1016/0753-3322(91)90153-k.

10

Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci.凝固酶阴性葡萄球菌分离株中糖肽类药物使用与替考拉宁敏感性降低之间的关系。

Eur J Clin Microbiol Infect Dis. 2004 May;23(5):375-9. doi: 10.1007/s10096-004-1129-1. Epub 2004 Apr 27.

引用本文的文献

1

A survey of the use of teicoplanin in patients with haematological malignancies and solid tumours.一项关于替考拉宁在血液系统恶性肿瘤和实体瘤患者中应用情况的调查。

Infection. 1998 Nov-Dec;26(6):389-95. doi: 10.1007/BF02770842.

2

Current perspectives on glycopeptide resistance.糖肽类耐药性的当前观点

Clin Microbiol Rev. 1995 Oct;8(4):585-615. doi: 10.1128/CMR.8.4.585.